Markets open

ResMed Inc.

RMD · NYSE

Analyst Consensus

Hold

14 analysts

$224

Current

—

Low

$231

Average

—

High

Average target implies +3.28% versus the current price.

The ratings synthesis for RMD has not been generated yet.

Rating Actions

No individual rating actions have been captured for RMDyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Covering Firms

B OF A GLBL RES

CITIGROUP

GOLDMAN SACHS

JEFFERIES & CO.

JP MORGAN SECUR

MIZUHO SECURITI

MORGAN STANLEY

NEEDHAM & CO.

OPPENHEIMER HLD

RBC CAPITAL

UBS

WILLIAM BLAIR

WOLFE RESEARCH

ZACKS RESEARCH

Symbol: RMD
Type: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
Country: North America
Exchange: NYSE

Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We're relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home.